Background and objective: Many studies have been conducted to investigate the association between angiotensin-converting enzyme (ACE) insertion (I)/deletion (D) gene polymorphism and vesicoureteral reflux (VUR) susceptibility. However, the results from those studies are still conflicting. We performed a meta-analysis of studies relating the ACE I/D gene polymorphism to the risk of VUR.
Method: We searched the databases of PubMed, Embase, Cochrane Library and CBM-disc (China Biological Medicine Database) as of 1 March 2011, and recruited the eligible investigations for this meta-analysis.
Results: Ten investigations were identified for the analysis of association between ACE I/D gene polymorphism and VUR risk: six in Caucasians, three in East-Asians and one in a Turkish population. All the investigations were performed in children. There was no marked association between ACE I/D gene polymorphism and VUR susceptibility/renal scar for overall populations, Caucasians and East-Asians. In the Turkish population, D allele and DD genotype were associated with the VUR susceptibility/renal scar. Furthermore, ACE I/D gene polymorphism was not associated with VUR progression.
Conclusions: D allele and DD genotype are risk factors for the VUR susceptibility/renal scar in Turkish children. However, more case-control association investigations on larger, stratified populations are required in the future.
MirshemiraniAKhaleghnejadTARoshanzamirF. Gil-Vernet antireflux surgery in children’s primary vesicoureteral reflux. Pediatr Surg Int2010; 26: 981-984.
2.
BriggsCEGuoCYSchoettlerC. A genome scan in affected sib-pairs with familial vesicoureteral reflux identifies a locus on chromosome 5. Eur J Hum Genet2010; 18: 245-250.
3.
BadeliHSadeghiMShafeO. Determination and comparison of mean random urine calcium between children with vesicoureteral reflux and those with improved vesicoureteral reflux. Saudi J Kidney Dis Transpl2011; 22: 79-82.
4.
HannulaAVenholaMRenkoM. Vesicoureteral reflux in children with suspected and proven urinary tract infection. Pediatr Nephrol2010; 25: 1463-1469.
5.
WengPLSanna-CherchiSHensleT. A recessive gene for primary vesicoureteral reflux maps to chromosome 12p11-q13. J Am Soc Nephrol2009; 20: 1633-1640.
6.
CordellHJDarlayRCharoenP. Whole-genome linkage and association scan in primary, nonsyndromic vesicoureteric reflux. J Am Soc Nephrol2010; 21: 113-123.
ZhouTBQinYHOuC. A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and steroid-sensitive nephrotic syndrome in children. J Renin Angiotensin Aldosterone Syst. Epub ahead of print23September2011. DOI: 10.1177/147032031142257910.1177/1470320311422579.
9.
QinYHZhouTBSuLN. Association between ACE polymorphism and risk of IgA nephropathy: A meta-analysis. J Renin Angiotensin Aldosterone Syst2011; 12: 215-223.
10.
YarenAOztopITurgutS. Angiotensin-converting enzyme gene polymorphism is associated with anemia in non small-cell lung cancer. Exp Biol Med (Maywood)2008; 233: 32-37.
11.
BonnetFPatelSLavilleM. Influence of the ACE gene insertion/deletion polymorphism on insulin sensitivity and impaired glucose tolerance in healthy subjects. Diabetes Care2008; 31: 789-794.
12.
ZhouTBOuCQinYH. Association of angiotensin converting enzyme insertion/deletion gene polymorphism with idiopathic nephrotic syndrome susceptibility in children: a meta-analysis. J Renin Angiotensin Aldosterone Syst2011; 12(4): 617-623.
13.
QinYHZhouTBSuLN. The efficacy of different dose intravenous immunoglobulin in treating acute idiopathic thrombocytopenic purpura: A meta-analysis of 13 randomized controlled trials. Blood Coagul Fibrinolysis2010; 21: 713-721.
14.
ZhouTBQinYHSuLN. ACE I/D gene polymorphism can’t predict the steroid responsiveness in Asian children with idiopathic nephrotic syndrome: a meta-analysis. PLoS One2011; 6: e19599.
15.
LiuKPLinCYChenHJ. Renin–angiotensin system polymorphisms in Taiwanese primary vesicoureteral reflux. Pediatr Nephrol2004; 19: 594-601.
16.
RigoliLChimenzRdi BellaC. Angiotensin-converting enzyme and angiotensin type 2 receptor gene genotype distributions in Italian children with congenital uropathies. Pediatr Res2004; 56: 988-993.
17.
NarasimhanKLMadhuKBalpinderK. Association of angiotensin converting enzyme and angiotensin type 2 receptor gene polymorphisms with renal damage in posterior urethral valves. J Pediatr Urol2010; 6: 560-566.
18.
EceATekesSGurkanF. Polymorphisms of the angiotensin converting enzyme and angiotensin II type 1 receptor genes and renal scarring in non-uropathic children with recurrent urinary tract infection. Nephrology (Carlton)2005; 10: 377-381.
19.
DudleyJJohnstonAGardnerA. The deletion polymorphism of the ACE gene is not an independent risk factor for renal scarring in children with vesico-ureteric reflux. Nephrol Dial Transplant2002; 17: 652-654.
20.
YonedaACascioSOueT. Risk factors for the development of renal parenchymal damage in familial vesicoureteral reflux. J Urol2002; 168: 1704-1707.
21.
AkmanBTarhanCAratZ. Renin–angiotensin system polymorphisms: A risk factor for progression to end-stage renal disease in vesicoureteral reflux patients. Ren Fail2009; 31: 196-200.
OzenSAlikasifogluMSaatciU. Implications of certain genetic polymorphisms in scarring in vesicoureteric reflux: importance of ACE polymorphism. Am J Kidney Dis1999; 34: 140-145.
YonedaAOueTPuriP. Angiotensin-converting enzyme genotype distribution in familial vesicoureteral reflux. Pediatr Surg Int2001; 17: 308-311.
26.
HaszonIFriedmanALPappF. ACE gene polymorphism and renal scarring in primary vesicoureteric reflux. Pediatr Nephrol2002; 17: 1027-1031.
27.
PardoRMalagaSCotoE. Renin–angiotensin system polymorphisms and renal scarring. Pediatr Nephrol2003; 18: 110-114.
28.
SekerliEKatsanidisDVavatsiN. ACE gene insertion/deletion polymorphism and renal scarring in children with urinary tract infections. Pediatr Nephrol2009; 24: 1975-1980.
29.
SavvidouABitsoriMChoumerianouDM. Polymorphisms of the TNF-alpha and ACE genes, and renal scarring in infants with urinary tract infection. J Urol2010; 183: 684-687.
30.
ParkHWKooJWKimJS. Association of angiotensin I converting enzyme gene polymorphism with reflux nephropathy in children. Nephron2000; 86: 52-55.
31.
ChoSJLeeSJ. ACE gene polymorphism and renal scar in children with acute pyelonephritis. Pediatr Nephrol2002; 17: 491-495.
32.
YimHEJungMJChoiBM. Genetic polymorphism of the renin–angiotensin system on the development of primary vesicoureteral reflux. Am J Nephrol2004; 24: 178-187.
33.
ErdoganHMirSSerdarogluE. Is ACE gene polymorphism a risk factor for renal scarring with low-grade reflux?Pediatr Nephrol2004; 19: 734-737.
34.
BoraitaAdelaRosaAHerasME. Cardiovascular adaptation, functional capacity and angiotensin-converting enzyme I/D polymorphism in elite athletes. Rev Esp Cardiol2010; 63: 810-819.
35.
Van der KnaapRSiemesCCoeberghJW. Renin–angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer: The Rotterdam Study. Cancer2008; 112: 748-757.
36.
ZhouTBQinYHSuLN. Insertion/deletion (I/D) polymorphism of angiotensin-converting enzyme gene in steroid-resistant nephrotic syndrome for children: a genetic association study and meta-analysis. Ren Fail2011; 33: 741-748.
37.
NikzamirANakhjavaniMGolmohamadiT. Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with metabolic syndrome in Iranians with type 2 diabetes mellitus. Arch Iran Med2008; 11: 3-9.
38.
FunadaAKonnoTFujinoN. Impact of renin–angiotensin system polymorphisms on development of systolic dysfunction in hypertrophic cardiomyopathy. Circ J2010; 74: 2674-2680.
39.
ZhouTBQinYHSuLN. Relationship between angiotensin-converting enzyme insertion/deletion gene polymorphism and susceptibility of minimal change nephrotic syndrome: A meta-analysis. Int J Nephrol2011; 2011: 360357.
40.
LambertDWClarkeNETurnerAJ. Not just angiotensinases: New roles for the angiotensin-converting enzymes. Cell Mol Life Sci2010; 67: 89-98.
41.
LubelJSHerathCBBurrellLM. Liver disease and the renin–angiotensin system: Recent discoveries and clinical implications. J Gastroenterol Hepatol2008; 23: 1327-1338.
42.
ZhouTBQinYHSuLN. The association between angiotensin-converting enzyme insertion/deletion gene variant and risk of focal segmental glomerulosclerosis: A systematic review and meta-analysis. J Renin Angiotensin Aldosterone Syst2011; 12(4): 624-633.
43.
Ribeiro-OliveiraAJrNogueiraAIPereiraRM. The renin–angiotensin system and diabetes: An update. Vasc Health Risk Manag2008; 4: 787-803.
44.
HusseinAAskarEElsaeidM. Functional polymorphisms in transforming growth factor-beta-1 (TGFbeta-1) and vascular endothelial growth factor (VEGF) genes modify risk of renal parenchymal scarring following childhood urinary tract infection. Nephrol Dial Transplant2010; 25: 779-785.
45.
SabasinskaAZoch-ZwierzWWasilewskaA. Laminin and transforming growth factor beta-1 in children with vesicoureteric reflux. Pediatr Nephrol2008; 23: 769-774.
46.
YimHEBaeISYooKH. Genetic control of VEGF and TGF-beta1 gene polymorphisms in childhood urinary tract infection and vesicoureteral reflux. Pediatr Res2007; 62: 183-187.
47.
Medical versus surgical treatment of primary vesicoureteral reflux: Report of the International Reflux Study Committee. Pediatrics1981; 67: 392-400.
48.
MurawskiIJWattCLGuptaIR. Vesico-ureteric reflux: Using mouse models to understand a common congenital urinary tract defect. Pediatr Nephrol2011; 26: 1513-1522.
49.
ZaffanelloMTardivoSCataldiL. Genetic susceptibility to renal scar formation after urinary tract infection: A systematic review and meta-analysis of candidate gene polymorphisms. Pediatr Nephrol2011; 26: 1017-1029.
